Oculis to present Licaminlimab at Eyecelerator @ AAO 2026

OCS•2026-10-07

Oculis will present its dry-eye drug candidate Licaminlimab at Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans. CEO Riad Sherif is scheduled to speak at 1:24 p.m. CDT, and the company will sponsor Neuro-Ophthalmology Subspecialty Day on Oct. 9.

1. AAO 2026 events

Oculis will present Licaminlimab at Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans. CEO Riad Sherif is scheduled to speak in the anterior segment showcase session at 1:24 p.m. CDT, and Oculis will sponsor the event’s Neuro-Ophthalmology Subspecialty Day on Oct. 9.

Oculis to present Licaminlimab at Eyecelerator @ AAO 2026

1. AAO 2026 events

Related News

VEON signs 10-year strategic agreement with Amdocs to modernize core IT operations

Europe Capital Partners sees AI investment broadening into power grids, data centers, copper and infrastructure

Adamas Trust, Inc.: KBW cuts target price to $9.25 from $9.75

B3 Now partners with Echelon AI to integrate AI agents into ServiceNow offering in Nordics

American Express Company: Jefferies cuts target price to $330 from $350